Vericel Corporation (VCEL) Covered Calls

Vericel Corp is engaged in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. It markets two cell therapy products including Carticel and Epicel.

You can sell covered calls on Vericel Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VCEL (prices last updated Fri 4:16 PM ET):

Vericel Corporation (VCEL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
59.07 +2.72 57.00 67.50 280K 805 2.8
Covered Calls For Vericel Corporation (VCEL)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 21 60 2.00 65.50 -8.4% -85.2%
Mar 21 60 2.00 65.50 -8.4% -47.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Vericel Corp. engages in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two cell therapy products in the United States, Carticel (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and Epicel (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area.Vericel was founded on March 24, 1989 and is headquartered in Cambridge, MA.